Your SlideShare is downloading. ×
EuroBioForum 2013 - Day 2 | Marc Lapage
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

EuroBioForum 2013 - Day 2 | Marc Lapage

207
views

Published on

EuroBioForum 2013 2nd Annual Conference …

EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013

=======================================

# REGIONAL PERSPECTIVES #

Genome Quebec, Canada:
Personalised medicine – Reaching the patient?

Marc LePage
President and CEO Genome Quebec

=======================================

http://www.eurobioforum.eu

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
207
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. PERSONALIZED MEDICINE:OPPORTUNITIES IN QUÉBECMarc LePage, President and CEO, Génome QuébecEuroBioForum 2nd Annual Conference 2013May 28, 2013Munich, Germany
  • 2. 1- Génome Québec in brief2- Platforms3- Personalized medicine portfolio4- What do we offer?5- What are we looking for?6- Personalized medicine projects (4-minute video)OUTLINESMay 28, 2013 2Marc LePage, President and CEO
  • 3.  Launched in 2000 Large-scale genomics research $750 million invested / 80 projects Health, Forestry, Agriculture, Environment, etc. Operates genomics platform 750 researchers at all major universities 90 employeesGÉNOME QUÉBEC IN BRIEFMay 28, 2013 3Marc LePage, President and CEO
  • 4. May 28, 2013 4McGILL UNIVERSITY AND GÉNOME QUÉBECINNOVATION CENTRE 175 employees:110 McGill (research): 15 research teams65 Génome Québec (management of services): averageexperience of GQ team > 4.5 years Number of users: > 800 research teams Annual revenues: $12 millionMarc LePage, President and CEO
  • 5. May 28, 2013 5TECHNOLOGIES AND APPLICATIONS Whole genome sequencing Exome sequencing (custom capture) RNA-Seq ChIP-Seq Epigenetics , methylation Transcriptomics, expression Genotyping (GWAS and custom) Validation (low throughput sequencing and genotyping) Bioinformatics Data analysisMarc LePage, President and CEO
  • 6. May 28, 2013 6INNOVATION CENTRE TODAY52%33%15%Geographical distributionof revenues of theInnovationCentre for 2011-2012QuébecRest of CanadaInternationalMarc LePage, President and CEO
  • 7. May 28, 2013 7INTERNATIONAL DISTRIBUTION OF USERS23 countries (2011-2012)Mostly in Europe!Marc LePage, President and CEO
  • 8. May 28, 2013 8COGSMAJOR CANADA/EUROPAN UNION COLLABORATIONMarc LePage, President and CEO
  • 9. May 28, 2013 9INNOVATION CENTRE AND EUROPEAN UNIONCitation“I am heading one of the largest genotype projects globally anda large part of our nearly 250,000 samples have beengenotyped at the McGill University and Génome QuébecInnovation Centre. We are very impressed with the expertiseand professionalism of the personnel, their project managementapproach and the capacity to deliver large-scale projects in atimely manner with very high quality standards.”Per Hall, MD, PhD; Medical Epidemiology and Biostatistics,Karolinska Institute,and Head of the COGS International ConsortiumMarc LePage, President and CEO
  • 10. May 28, 2013 10PERSONALIZED MEDICINE PORTFOLIOPrincipalInvestigatorInstitution Project TitleTotal Budget($)Patrick CossetteCentre hospitalier universitaire del’Université de Montréal (CHUM)Personalized medicine in the treatment of epilepsy 10,833,759Nada JabadoResearch Institute of theMcGill University Health CentreBiomarkers for pediatric glioblastoma throughgenomics and epigenomics5,074,844Claude PerreaultHôpital Maisonneuve-Rosemontand the Institute for Research inImmunology and Cancer ofUniversité de MontréalPersonalized cancer immunotherapy 13,486,784John D. RiouxMontreal Heart Institute ofUniversité de MontréalInflammatory bowel diseases Genomic MedicineConsortium (iGenoMed)9,892,162François RousseauUniversité Laval andCHU de QuébecPersonalized genomics for prenatal aneuploidyscreening using maternal blood (PEGASUS)10,459,731Guy SauvageauInstitute for Research inImmunology and Cancer ofUniversité de MontréalInnovative chemo-genomic tools to improve clinicaloutcome in acute myeloid leukemia11,325,631Jacques SimardUniversité Laval andCHU de QuébecPersonalized risk stratification for the prevention andearly detection of breast cancer11,382,455Jean-Claude TardifMontreal Heart Institute ofUniversité de MontréalPersonalized medicine strategies for moleculardiagnostics and targeted therapeutics of cardiovasculardiseases9,443,0024 collaborations 6,666,950Marc LePage, President and CEO
  • 11. May 28, 2013 11WHAT DO WE OFFER? International collaborations Access to genomics platform (sequencing, genotyping) CARTaGENE/Genizon: Population cohorts of Québec« Colloque sur la médecine personnalisée: Parce que lessolutions sont dans nos gènes »Investigators and health policy meeting that will be heldOctober 1, 2013, in Québec CityMarc LePage, President and CEO
  • 12. May 28, 2013 12WHAT DO WE WANT?Today Translational strategies: successful models and approaches Collaborators, cohortsTomorrow Clinical genomics: lessons learned Genomics and prevention (healthy lifestyle habits…)Marc LePage, President and CEO
  • 13. May 28, 2013 13PERSONALIZED MEDICINE PROJECTSMarc LePage, President and CEO